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ABSTRACT 
Chromosomal mosaicism in human preimplantation embryos is a common cause of 
spontaneous abortions, however, our knowledge of its etiology is limited. We used multicolor 
fluorescence in situ hybridization (FISH) painting to investigate whether paternally-transmitted 
chromosomal aberrations result in mosaicism in mouse 2-cell embryos. Paternal exposure to 
acrylamide, an important industrial chemical also found in tobacco smoke and generated during 
the cooking process of starchy foods, produced significant increases in chromosomally defective 
2-cell embryos, however, the effects were transient primarily affecting the postmeiotic stages of 
spermatogenesis. Comparisons with our previous study of zygotes demonstrated similar 
frequencies of chromosomally abnormal zygotes and 2-cell embryos suggesting that there was no 
apparent selection against numerical or structural chromosomal aberrations. However, the 
majority of affected 2-cell embryos were mosaics showing different chromosomal abnormalities 
in the two blastomeric metaphases. Analyses of chromosomal aberrations in zygotes and 2-cell 
embryos showed a tendency for loss of acentric fragments during the first mitotic division of 
embryogenesis, while both dicentrics and translocations apparently underwent proper 
segregation. These results suggest that embryonic development can proceed up to the end of the 
second cell cycle of development in the presence of abnormal paternal chromosomes and that 
even dicentrics can persist through cell division. The high incidence of chromosomally mosaic 2-
cell embryos suggests that the first mitotic division of embryogenesis is prone to missegregation 
errors and that paternally-transmitted chromosomal abnromalities increase the risk of 
missegregation leading to embryonic mosaicism. 
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INTRODUCTION 
 Constitutional chromosomal mosaicism indicates the presence of two or more 
chromosomal complements within an individual (Kalousek, 2000). The most common case of 
mosaicism is the presence of trisomic cells within normal diploid cells, although other 
chromosomal abnormalities such as sex chromosome monosomy or structural aberrations are 
also observed (Kalousek, 2000). Mosaic aneuploidy is found in 1-2% of prenatal diagnoses of 
chorionic villus samples (Kalousek et al., 1991), 0.3% in those performed by amniocentesis 
(Hsu, 1992) and 0.02% among livebirths (Hassold et al., 1996). Fluorescence in situ 
hybridization (FISH) analyses suggest that as many as 50% of early human embryos are mosaic 
(Bielanska et al., 2002a; Bielanska et al., 2002b; Delhanty et al., 1997; Gonzalez-Merino et al., 
2003; Munné et al., 1998; Munné et al., 1994; Vorsanova et al., 2005). Mosaicism for 
chromosomal structural abnormalities has also been reported, although it is relatively rare (Hsu, 
1992).   
A critical question in the development of mosaicism is the time at which the second cell 
line appears. Mosaicism occurring at the first cleavage division results in an embryo in which all 
cells are abnormal; mosaicism occurring at the second cleavage results in an embryo in which 
half of the cells are abnormal and so on. When the second cell line arises at or shortly after the 
first postzygotic division, is likely that mosaicism will be present in both the fetus and the 
placenta (Kalousek and Vekemans, 1996). However, if mosaicism arises late during the 
preimplantation development, mosaic cells will constitute only a small portion of the blastocyst. 
In these cases, because the fetus is derived from only few of the cells that make up the blastocyst 
(Markert and Petters, 1978), mosaicism is generally confined to the extra embryonic tissues 
(Lestou et al., 2000).   
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Despite the high incidence of chromosomal mosaicism in human conceptuses, our 
knowledge of its etiology is limited. Mitotic nondisjunction and anaphase lag are thought to be 
the most common error producing mosaicism in early embryos (Kalousek, 2000). Mitotic errors 
account for the generation of chromosome 21 mosaicism in the majority of mosaic embryos 
(Katz-Jaffe et al., 2004; Katz-Jaffe et al., 2005), and in ~4% of all Down syndromes 
(Antonarakis et al., 1993). Anaphase lag is considered the most common error producing 
45,X/46,XX mosaicism (Robinson et al., 1995). There is also evidence that chromosomal 
aberrations can predispose to the formation of mosaicism during early development. High rates 
of mosacisms have been observed in the embryos from Robertsonian (Emiliani et al., 2003) or 
reciprocal translocation carriers (Iwarsson et al., 2000).  
Acrylamide (AA) is an important industrial chemical classified as a probable human 
carcinogen (IARC, 1994). Tobacco smoking is a significant source of AA exposure in the human 
population (Smith et al., 2000; Vesper et al., 2007). In addition, AA is formed in starchy foods as 
a by-product of high-temperature cooking processes (Mottram et al., 2002; Rosen and Hellenas, 
2002; Stadler et al., 2002; Tareke et al., 2002). Daily human exposures to AA are estimated in 
1.4-18.6 µg/kg for daily workplace inhalation exposure and 0.75 µg/kg/d via food consumption 
(Manson et al., 2005). A recent assessment of the reproductive risks of AA exposure concluded 
that there is some concern for adverse reproductive and developmental effects, including 
heritable effects, for exposure in occupational settings (Manson et al., 2005). AA has been 
extensively studied both in vivo and in vitro, although at doses much higher than those 
encountered by humans (Dearfield et al., 1995; Manson et al., 2005). In mice, AA induces 
chromosomal damage at first-cleavage (Marchetti et al., 1997; Marchetti et al., 1996; 
Pacchierotti et al., 1994), abnormalities in preimplantation development (Titenko-Holland et al., 
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1998), dominant lethal (DL) mutations (Shelby et al., 1986), heritable translocations (HT) 
(Adler, 1990; Adler et al., 1994; Shelby et al., 1987) and specific locus mutations (Ehling and 
Neuhauser-Klaus, 1992; Russell et al., 1991), particularly after treatment of late spermatids and 
early spermatozoa. The high sensitivity of these cells is thought to result from two factors. 
Protamines, basic proteins that replace histones during spermiogenesis (Meistrich et al., 1978), 
are considered the primary site of AA-alkylation (Sega et al., 1989). Secondly, sperm and late 
spermatids have reduced DNA repair capacity as compared with early spermatids and the other 
spermatogenic cells (Baarends et al., 2001; Olsen et al., 2005; Sega, 1974; Sega, 1979; Sega et 
al., 1989; Sotomayor and Sega, 2000). Therefore, DNA or chromatin lesions induced during late 
spermatogenesis can accumulate and be transmitted to the zygote where they can be converted 
into chromosomal aberrations (Marchetti and Wyrobek, 2008).  
We developed a method for detecting both stable and unstable chromosomal 
rearrangements in mouse zygotes using a combination of multicolor chromosome painting 
probes (PAINT) and 4,6-diamidino-2-phenylindole (DAPI) staining (Marchetti et al., 1996) and 
demonstrated that unstable and stable chromosomal aberrations in mouse zygotes are predictive 
of embryonic death after implantation and of translocation carriers at birth (Marchetti et al., 
2004; Marchetti et al., 2001; Marchetti et al., 2007; Marchetti et al., 1997). Here we report the 
application of our PAINT/DAPI method to investigate the genesis of chromosomal mosaicism in 
2-cell embryos after treatment of male mice with AA, and specifically to determine whether: (a) 
the presence of chromosomal aberrations in zygotes predisposes to chromosomal missegregation 
during the first mitotic division; and (b) unstable chromosomal aberrations persisted during the 
early embryonic stages of mammalian development. 
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MATERIALS AND METHODS 
Animals, chemical treatment of males, and hormone administration of females. 
Male and female B6C3F1 mice (Harlan Sprague-Dawley Inc., Indianapolis, IN, USA) 
between 8 and 12 weeks of age at the beginning of the experiments were used. They were 
maintained under a 12 hr light/12 hr dark photoperiod (light from 6.00 am to 6.00 pm) at room 
temperature of 21-23° C and relative humidity of 50 ± 5%. Pelleted food and sterilized tap water 
were provided at libitum. The use of animals in these experiments was approved by the 
Lawrence Livermore National Laboratory Institutional Animal Care and Use Committee. 
Human exposure to AA occurs mostly through oral and inhalation routes (Manson et al., 
2005). However, because of the inherent animal-to-animal variation in exposure associated with 
these routes of exposures, and because previous animal studies have shown that different routes 
of exposures (ip, dermal, drinking water etc) produced qualitatively similar results (Dearfield et 
al., 1995), AA was administered intraperitoneally (i.p.). Male mice received 5 consecutive daily 
doses of 50 mg/kg AA (CAS No. 79-06-1, Fisher Scientific, Fair Lawn, NJ) dissolved in sterile 
distilled water. AA solution was prepared fresh every day and was administered i.p. at the final 
volume of 0.01 ml/g b.w. every morning. Groups of 12 similarly treated males were mated with 
untreated females at 2.5, 6.5, 9.5, 12.5, 20.5, 27.5, 41.5 and 48.5 days after the last AA injection. 
Rather than mimicking the doses humans are exposed to, the AA dose and timepoints utilized in 
this study were chosen to allow comparisons with previous studies in mouse zygotes (Marchetti 
et al., 1997; Pacchierotti et al., 1994) and in developing embryos (Shelby et al., 1987; Shelby et 
al., 1986). For each time point, at least three repetitions (each with a different group of treated 
males) were performed and the data combined. Control males received 5 daily injections of 
sterile distilled water (0.01 ml/g b.w.), and were mated with untreated females at 2.5, 6.5, 9.5 and 
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12.5 days after the last injection. No differences in the frequencies of embryos with 
chromosomal aberrations were found among the 4 groups of control matings and the results were 
pooled. 
B6C3F1 females were superovulated using an i.p. injection of 7.5 I.U. of pregnant mare's 
serum (PMS, Sigma Chemical Co., St. Louis. MO, USA), followed 48 hr later by an i.p. 
injection of 5.0 I.U. of human chorionic gonadotrophin (HCG, Sigma Co.). Immediately after 
HCG injection (1.00 pm), the females were caged with treated or untreated males (1:1). The 
following morning females were checked for the presence of vaginal plugs. Mated females 
received an i.p. injection of 0.08 mg of colchicine (CAS No. 64-86-8, Sigma Co.) dissolved in 
0.2 ml of distilled water, 44 hr after HCG to arrest embryonic development at the metaphase 
stage of the second cleavage division. Females were euthanized by CO2 inhalation 6 hr after 
colchicine injection and 2-cell embryos were harvested and processed according to the mass 
harvest procedure (Mailhes and Yuan, 1987). 
 
Fluorescence in situ hybridization  
Prepared slides were examined with a 10x objective under phase contrast to determine 
the number of eggs that were fertilized, the number of fertilized eggs that progressed past the 
first mitotic division, and the number of 2-cell embryos that reached the second-cleavage 
metaphase stage. Slides were then stored in nitrogen atmosphere at -20˚C until used for FISH. 
Five composite DNA painting probes were used: four biotin-labeled probes specific for 
chromosomes 1, 2, 3 or X plus a digoxigenin-labeled probe specific for chromosome Y (Applied 
Genetics Laboratories, Inc., Melbourne, FL). Hybridization and washing conditions were as 
previously described (Marchetti et al., 1996). Amplification of the fluorescent signals was 
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achieved using the Biotin-Digoxigenin Dual Color Detection Kit (Oncor, Gaithersburg, MD) 
following the manufacturer specifications. DAPI at 0.25 µg/ml diluted in antifade mounting 
medium (Oncor) was used for counterstaining. The 5-probe cocktail produced two sets of 
fluorescent patterns in normal male and female 2-cell embryos. Male embryos showed one red 
signal for the Y chromosome and 7 green signals corresponding to the three couples of 
autosomes and one copy of the X chromosomes in each metaphase (Figure 1A), while female 
embryos showed 8 green signals per metaphase (the three couples of autosomes plus two copies 
of the X chromosome). 
 
Metaphase analysis and scoring 
A Zeiss Axioplan fluorescent photomicroscope was equipped with a double-bandpass 
excitor (81P102, Chroma Technology, Brattleboro, VT) for visualizing the red (rhodamine) and 
green (FITC) signals; a triple-bandpass filter set (61002, Chroma Technology) for the 
simultaneous detection of the red, green, and blue (DAPI) signals; and another DAPI filter set 
(487901, Zeiss) for visualizing DAPI fluorescence only. Metaphase 2-Cl embryos were analyzed 
both by DAPI staining to detect aberrations not involving painted chromosomes and by PAINT 
analysis to detect aberrations involving painted chromosomes. Scoring of the painted aberrations 
was done according to the PAINT nomenclature system (Marchetti et al., 1996; Tucker et al., 
1995). A metaphase was considered abnormal regardless of whether the chromosome aberration 
was detected by PAINT or DAPI analysis. Also, an embryo was considered abnormal even when 
the chromosomal aberration was present in only one of the two metaphases.  
 
Statistical analysis 
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The ANOVA test was used for the analysis of the results. When the numbers of events 
was less than 5, the Fisher’s exact test was used. 
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RESULTS 
Baseline levels of chromosomal abnormalities in mouse 2-cell embryos  
The baseline frequencies of chromosomal abnormalities in 2-cell embryos after mating of 
untreated male and female mice are reported in Table 1. Six out of 358 2-cell embryos obtained 
from untreated mice showed chromosomal structural aberrations; five cases were a chromosomal 
acentric fragment and one was an interstitial chromatid deletion. In all cases, the chromosomal 
aberration was present in only one metaphase, while the other appeared normal. Affected 
embryos were therefore mosaics for chromosomal structural aberrations.  
Among 2-cell embryos analyzed for numerical abnormalities, 0.6% were aneuploid (each 
metaphase contained 41 chromosomes), and 3.4% were triploid (each metaphase contained ~60 
chromosomes). Three 2-cell embryos (0.9%) were numerical mosaic embryos (41 chromosomes 
in one metaphase and 39 in the other), presumably originated from a nondisjunctional event 
during the first mitotic division after fertilization.  
To assess the effects of spontaneous chromosomal abnormalities on embryonic 
development, we compared the frequencies of chromosomally abnormal 2-cell embryos 
recovered in control matings from the AA exposure study with those in zygotes collected from 
control matings from other experiments that were undergoing in our laboratory at the same time 
of the 2-cell embryo experiment. The comparison (Table1) showed that showed that numerical 
abnormalities were present at similar frequencies between the two embryonic stages and that 
there was a marginally significant (P=0.08) three-fold increase in the frequencies of 2-cell 
embryos with chromosomal structural aberrations with respect to zygotes. These results indicate 
that in unexposed matings neither structural nor numerical abnormalities, including the presence 
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of an additional haploid genome, affected embryonic development up to the 2-cell metaphase 
stage. 
 
Pre- and post-fertilization toxicity induced by paternal exposure to acrylamide 
We investigated the effects of AA exposure of male germ cells on pre- and post 
fertilization toxicity. The former is manifested as a reduction in the number of eggs that are 
fertilized; the latter is manifested as a reduction in the number of fertilized eggs that proceed past 
the first mitotic division and reach the metaphase stage of the second cell division. AA treatment 
of male mice prior to mating induced pre-fertilization toxicity only after matings that sampled 
late spermatids (9.5 dpt). At this time point the frequencies of fertilized embryos were reduced to 
71% versus 83% in control matings (P<0.01; Table 2). There was little evidence for an effect on 
the number of fertilized eggs that were unable to complete the first cell cycle of development and 
proceed to the 2-cell stage. As shown in Table 2, although the frequencies of one-cell embryos 
were higher than controls at all mating points, no statistically significant differences were found 
due to large variation among control matings in the frequencies of one-cell embryos (range 3.4-
20.1). This large variation is most likely an artifact of the preparation procedure. In fact, the great 
majority of embryos classified as one-cell embryos had one set of 40 mitotic chromosomes and 
most likely represented 2-cell embryos in which the metaphase from the second blastomere was 
lost during the fixation process rather than zygotes that had arrested at the metaphase stage of the 
first cleavage division.  
AA treatment of male mice prior to mating induced a significant reduction in the numbers 
of 2-cell embryos that reached the metaphase stage in matings within the repair deficient window 
of spermatogenesis (2.5-12.5 dpt) with respect to the control value (P<0.05, last column of Table 
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2). As shown in Table 2, this was due to a significant increase in the percentages of 2-cell 
embryos that were still in interphase at the time of collection suggesting that paternal exposure to 
AA induced cell cycle delay, an effect also found in bone marrow cells (Gassner and Adler, 
1996). Finally, the percentages of asynchronous 2-cell embryos (i.e. those embryos in which one 
cell was at the metaphase stage and the other in interphase at the time of collection, Figure 1B) 
were not affected by paternal exposure to AA.  
 
Chromosomal structural aberrations detected by PAINT/DAPI analysis 
As shown in Table 3, paternal treatment with AA induced high frequencies of 
chromosomally abnormal 2-cell embryos (>50%) after treatment of epididymal sperm (2.5 dpt), 
testicular sperm (6.5 dpt) and late spermatids (9.5 dpt). Testicular sperm were the most sensitive 
cell type for the induction of chromosome structural aberrations (statistically different from 2.5 
and 9.5 dpt) with 82% of the 2-cell embryos presenting with chromosome structural aberrations. 
The frequencies of embryos with structural aberrations decreased to 19% after treatment of 
elongating spermatids (12.5 dpt) and 5.0% after treatment of round spermatids (20.5 dpt). 
Chromosomal aberrations were not significantly increased with respect to the control value after 
treatment of pachytene spermatocytes (27.5 dpt), differentiating spermatogonia (41.5 dpt) or 
stem cells (48.5 dpt). 
Testicular spermatozoa were also the germ cell type with the highest amount of 
chromosomal damage (Table 4). For this analysis, each aberrant chromosome was considered 
independently, that is, the two translocated chromosomes produced by an exchange event were 
treated separately. Similarly, acentric fragments produced by an exchange event and associated 
with dicentrics were included in the acentric fragment class. The data for PAINT analysis are 
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given in cell-equivalents (Marchetti et al., 1996; Tucker et al., 1995). As shown in Table 4, each 
type of aberration was most prevalent at 6.5 dpt mating time when the total number of 
chromosomal aberrations per embryo was above 3.3 by both PAINT and DAPI analyses, while it 
was less than 2.4 per embryo at 2.5 dpt and decreased to around 1.5 at 9.5 dpt. In addition, there 
was good agreement between the data obtained by PAINT and DAPI analyses suggesting that the 
painted chromosomes were not preferentially involved in aberration formation. 
 
Chromosomal mosaicism in 2-cell embryos 
PAINT/DAPI analysis of mouse 2-cell embryos showed that paternal treatment with AA 
induced mosaicism for structural chromosomal aberrations (Table 3). The majority of abnormal 
embryos, irrespective of mating time point, were mosaics, i.e., the two metaphases had a 
different karyotype (Figure 1C-D). In the treated groups, the majority of 2-cell embryos had 
chromosomal structural aberrations in both metaphases, but the aberrations were of different 
types (mosaic abnormal/abnormal in Table 3). Conversely, all abnormal embryos found in the 
control group had one metaphase with a chromosomal aberration while the other appeared to be 
normal (mosaic abnormal/normal in Table 3). A third group of embryos were structurally 
abnormal with the apparently same chromosomal aberration in both metaphases (non-mosaic in 
Table 3).  
 
Numerical abnormalities in 2-cell embryos 
Paternal exposure to AA also induced numerically abnormal 2-cell embryos (Figure 1E). 
As shown in Table 5, the majority of the embryos were hypodiploid in one or both metaphases. 
At 6.5 dpt, the most sensitive time for the induction of chromosomal structural aberrations (Table 
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3), over 72% of the embryos were hypodiploid. Hyperdiploid non-mosaic embryos (41 
chromosomes in both metaphases) and triploid non-mosaic embryos (60 chromosomes in both 
metaphases) were also found, but their frequencies were not different with respect to controls. 
Numerically abnormal mosaic 2-cell embryos (those having 41 chromosomes in one metaphase 
and 39 in the other; Figure 1E) were increased at least three-fold at 2.5, 6.5 and 9.5 dpt, however, 
none of these values were statistically different from controls. When these mating points were 
pooled, the increase was statistically significant (P<0.01, Fisher’s exact). This indicates that high 
levels of chromosomal aberrations induced by paternal exposure to AA during the repair 
deficient window of spermatogenesis may result in the production of mosaic aneuploidy in 2-cell 
embryos. 
 
Persistence of chromosomal aberrations 
We analyzed the persistence of the various types of chromosomal structural aberrations in 
2-cell embryos (present study) versus zygotes (Marchetti et al., 1997) to determine whether the 
number per metaphase of stable aberrations would remain the same in zygotes and embryos, 
while the number of unstable aberrations would decrease. For these comparisons, we divided by 
two the data shown in Table 4 to obtain the number per metaphase of each class of abnormality 
to account for the fact that each 2-cell embryo has two metaphases, while zygotes have only one 
metaphase. We then compared these numbers with those obtained in the prior zygote experiment. 
As shown in Figure 2A, the sum of the total number of aberrations per metaphase was slightly 
lower in 2-cell embryos than in zygotes (4.14 vs 4.71). Interestingly, this was due mostly to a 
loss of acentric fragments while dicentric frequencies were similar between zygotes and 2-cell 
embryos. Figures 2B and 2C compare the number of dicentrics and acentric fragments found in 
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zygotes and 2-cell embryos at the four mating times with the highest incidence of chromosomal 
aberrations. The frequencies of acentric fragments were consistently lower in 2-cell embryos vs 
zygotes but the time course was similar. As expected, the frequencies of translocations were 
similar between zygotes and 2-cell embryos (data not shown). These results suggest that there is 
a tendency for loss of acentric fragments during the first mitotic division, while both dicentrics 
and translocations apparently undergo proper segregation without loss. 
 
Comparisons with dominant lethality and heritable translocation data 
In previous studies (Marchetti et al., 2004; Marchetti et al., 2001; Marchetti et al., 2007; 
Marchetti et al., 1997), we reported a very good correlation between the percentages of zygotes 
with unstable chromosomal aberrations and embryonic lethality and between stable 
chromosomal aberrations and the percentages of offspring with reciprocal translocations. We 
therefore determined whether PAINT/DAPI analysis of 2-cell embryos also provided good 
estimates of embryonic lethality and of translocation carriers at birth. The study on the induction 
of dominant lethality after paternal exposure to 5 x 50 mg/kg AA (Shelby et al., 1986) reported 
frequencies of dead implants in each of four 3-day post-treatment mating intervals as 67% (0.5-
3.5 dpt), 68% (4.5-7.5 dpt), 37% (8.5-11.5 dpt) and 12% (12.5-13.5 dpt). Each one of our first 4 
mating times is contained within one of these intervals. Using PAINT/DAPI analysis, the 
frequencies of 2-cell embryos with unstable aberrations, which are expected to die in utero 
because of loss of genetic material, were: 66% (98 out 149), 80% (115 out 143), 48% (102 out 
212), and 19% (57 out 307) at 2.5, 6.5, 9.5 and 12.5 dpt mating times, respectively. As shown in 
Figure 3, the cytogenetic data for 2-cell embryos agreed very well with both the DL results 
(Shelby et al., 1986) and our previous study in zygotes (Marchetti et al., 1997). It is interesting to 
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note that the concordance between 2-cell embryos with unstable aberrations and DL results is 
already good without considering embryos with one normal and one abnormal metaphase, 
suggesting that such mosaic 2-cell embryos, which have 50% of normal cells, survive and 
produce viable offspring. 
Two studies investigated the induction of translocation carriers in the offspring of mice 
treated with AA (Adler, 1990; Shelby et al., 1987). In both studies, male mice treated with 5 x 50 
mg/kg AA were bred with untreated females between 7 and 10 days after the last injection. 
(Shelby et al., 1987) analyzed only the male offspring and found that 39% had heritable 
translocations. (Adler, 1990) analyzed both male and female offspring and reported a combined 
frequency of 22% (Figure 4). Using our 9.5 dpt data point, which is within their 7-10 day 
window, we analyzed 200 2-cell embryos which corresponded to 74 cell-equivalents (Table 4): 
41 2-cell embryos showed unstable aberrations, 8 had reciprocal translocations and 25 were 
without aberrations. Assuming that the 41 2-cell embryos with unstable aberrations will result in 
embryonic lethality, a total of 33 embryos are expected to produce viable offspring. As shown in 
Figure 4, the proportion of 2-cell embryos with stable aberrations (24 %, 8 out 33 2-cell 
embryos) is in agreement with the frequencies of offspring with heritable translocations reported 
using the standard HT method and paralleled the findings obtained in zygotes (Marchetti et al., 
1997). 
Overall, the findings shown in Figures 3 and 4 indicate that the frequencies of 
chromosomal aberrations in zygotes and 2-cell embryos are consistent with each other and are a 
good predictor of embryonic fate for death after implantation and birth with reciprocal 
translocations. 
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DISCUSSION 
We applied PAINT/DAPI analysis to mouse 2-cell embryos to investigate the induction 
of chromosomal mosaicism after paternal treatment with AA and the effect of chromosomal 
abnormalities on embryonic development from first cleavage to second cleavage. Chromosomal 
aberrations of paternal origin were significantly increased in embryos produced from matings 
that sampled treated postmeiotic cells. We also found that paternal exposure to AA resulted in 
extensive chromosomal mosaicism in 2-cell embryos. Comparisons with results obtained in 
zygotes indicated that there was no apparent selection against numerical or structural 
chromosomal aberrations between the first and second metaphase after fertilization and that 
dicentrics persisted through the first cell division at unchanged frequencies.  
Paternal exposure to AA before mating significantly increased the frequencies of 2-cell 
embryos with chromosomal aberrations of paternal origin but the effects were transient primarily 
affecting the postmeiotic stages of spermatogenesis. The time course of AA-induced 
chromosomal aberrations in mouse 2-cell embryos after treatment of male germ cells observed in 
our study compared very well with the prior experiment in mouse zygotes (Marchetti et al., 
1997) (Figure 2) and is in agreement with the general pattern of sensitivity of male germ cells to 
alkylating agents (Marchetti and Wyrobek, 2005). At variance with our study in zygotes, we 
could not repeat the finding of a significant increase in paternally-transmitted chromosomal 
aberrations after AA treatment of pachytene spermatocytes (28.5 dpt). However, the frequencies 
of zygotes and 2-cell embryos with chromosomal aberrations observed in matings that sampled 
pachytene spermatocytes were not different (3.4% vs 4.8%, p=0.48) and the major difference 
between the two studies was the 3-fold increase in the frequencies of 2-cell embryos with 
chromosomal aberrations found in controls (Table 1). In all six chromosomally abnormal 2-cell 
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embryos observed in controls, the chromosomal aberration was present in only one metaphase 
suggesting that the aberration had been formed during the second cell cycle of embryonic 
development or because of an asymmetrical distribution at first cleavage. The higher baseline 
level of chromosomal abnormalities in 2-cell embryos with respect to zygotes, a finding that 
supports results obtained with a different strain of mice (Tusell et al., 2004), suggests that the 
analysis of mouse zygotes may be a more sensitive approach for detecting small effects.  
A major finding of our study was the presence of extensive chromosomal structural 
mosaicism in 2-cell embryos after paternal exposure to AA. Of the 425 2-cell embryos with 
chromosomal aberrations over 80% were mosaics, and two thirds of these had chromosomal 
aberrations in both blastomeric metaphases. The differential sensitivity of the various stages of 
spermatogenesis to the clastogenic effects of AA highlighted a direct correlation between the 
amount of chromosomal damage and the fraction of mosaic abnormal/abnormal embryos. 2-cell 
embryos mosaic abnormal/abnormal were highest after matings that sampled testicular sperm 
(6.5 dpt), followed by epididymal sperm (2.5 dpt) and late spermatids (9.5 dpt). These three 
timepoints were also those with the highest percentages of chromosomally abnormal 2-cell 
embryos (Table 3) and the highest amount of chromosomal damage (Table 4). The positive 
correlation between amount of chromosomal aberrations and rate of mosaicism is undoubtedly a 
consequence of the fact that the higher the number of chromosomal aberrations in a zygote the 
lower is the chance that all the aberrations will be distributed equally between the two daughter 
cells. There is also evidence suggesting that the first mitotic division in the embryo may be prone 
to chromosome missegregation regardless of the presence of chromosome structural 
abnormalities (Bean et al., 2001). Our results show that paternally-transmitted chromosomal 
aberrations can be an etiological cause of chromosomal mosaicism during the first cleavage 
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division of mammalian embryogenesis and may be partly responsible for the high levels of 
mosaicism observed in human preimplantation embryos (Bielanska et al., 2002a; Bielanska et al., 
2002b; Delhanty et al., 1997; Gonzalez-Merino et al., 2003; Munné et al., 1998; Munné et al., 
1994; Vorsanova et al., 2005). 
Comparisons of the present results with those obtained in zygotes (Marchetti et al., 1997) 
allowed us to study the persistence of specific types of chromosomal aberrations between the 
first and second cleavage division. We found similar frequencies of different types of 
chromosomal aberrations in zygotes and 2-cell embryos (Figure 2). Only the frequencies of 
acentric fragments were consistently lower in 2-cell embryos suggesting that some acentric 
fragments were lost during the first cleavage division. The frequencies of dicentrics were similar 
between zygotes and 2-cell embryos, which is seemingly at variance with a great body of 
evidence from somatic cells that shows that dicentric frequencies tend to decline with every 
mitotic division (Bauchinger et al., 2001; Carrano, 1973a; Carrano, 1973b; Tucker et al., 2005). 
These findings can be explained by the fact that the decline in dicentric frequencies in somatic 
tissues is more a consequence of the elimination of cells with unstable aberrations by apoptosis 
(Carrano, 1973a; Carrano, 1973b) than the actual loss of dicentrics. Apoptosis, however, is not 
observed during the early embryonic stages (Brison and Schultz, 1997; Hardy et al., 2001). A 
dicentric in a zygote (or a somatic cell for that matter) has two segregation possibilities: the first 
involves a parallel orientation, in which both centromeres of a chromatid orient to the same 
spindle pole and each blastomere inherits an intact dicentric. The second possibility involves a 
non-parallel orientation in which the two centromeres of a chromatid orient to opposite poles and 
the original dicentric undergos the well-characterized breakage-fusion-bridge cycle (Gisselsson 
et al., 2000; Koshland et al., 1987; Lukaszewski, 1995; McClintock, 1939), with the result that 
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each blastomere would still inherit a dicentric. Therefore, regardless of centromeric orientation, 
the persistence of 2-cell embryos with unstable aberrations assures that the frequencies of 
dicentrics per cell would remain constant between zygotes and 2-cell embryos. Indeed, data in 
oocytes suggest that dicentrics can survive the two meiotic divisions and persist into the first few 
embryonic divisions (Koehler et al., 2002). 
Our results of similar frequencies of zygotes and 2-cell embryos with chromosomal 
abnormalities seems at variance with a previous study that found that chromosomal aberrations 
were significantly higher in zygotes than in 2-cell embryos after exposure of male mice to 
ionizing radiation (Tusell et al., 2004). The authors suggested that this was due to the unstable 
nature of most of the detected aberrations and/or death of zygotes carrying chromosomal 
aberrations. We found little evidence for the death of zygotes with chromosomal aberrations. In 
fact, the frequencies of 2-cell embryos with chromosomal aberrations were very similar to those 
of chromosomally abnormal zygotes at all mating times (Table 3 and Figure 5). Additionally, as 
in previous studies with zygotes (Marchetti et al., 2004; Marchetti et al., 2001; Marchetti et al., 
2007; Marchetti et al., 1997; Marchetti and Wyrobek, 2008), the estimates of embryonic lethality 
based on the frequencies of 2-cell embryos with chromosomal aberrations matched the reported 
frequencies of dominant lethality (Figure 3). This provides compelling evidence that 
chromosomal aberrations do not affect embryonic development during the preimplantation 
period. Indeed, a recent study demonstrated that mosaic embryos can develop and implant into 
the uterine tissue but die soon thereafter (Lightfoot et al., 2006). There are several differences 
between our study and that of (Tusell et al., 2004), including the agents utilized which induce 
different spectra of DNA lesions, and the fact that we allowed embryonic development to 
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proceed in vivo, while (Tusell et al., 2004) collected 2-cell embryos by culturing zygotes for 24 
hr. It is possible that these differences may be responsible for the differing outcomes.  
Our study shows that the PAINT/DAPI analysis of mouse 2-cell embryos has both 
strengths and weaknesses with respect to the analysis of mouse zygotes. As the PAINT/DAPI 
analysis of mouse zygotes (Marchetti et al., 2004; Marchetti et al., 2001; Marchetti et al., 2007; 
Marchetti et al., 1997), the analysis of 2-cell embryos is a powerful approach for investigating 
paternally-transmitted chromosomal abnormalities and their consequences for embryonic 
development. Unlike mouse zygotes, 2-cell embryos allow to study the persistence of 
chromosomal aberrations and the induction of mosaicism and other complex abnormalities that 
are thought to arise after fertilization. However, it may be at a disadvantage with respect to 
zygotes for detecting small effects of paternal exposure because of the higher background level 
of chromosomal aberrations seen in untreated matings that reduces the sensitivity of the assay.  
The analysis of mouse 2-cell embryos seems less efficient in detecting mutagen-induced 
effects on fertilization than the analysis of mouse zygotes. In the present study, pre-fertilization 
toxicity was confined to matings that sampled late spermatid (9.5 dpt) only, while in the zygote 
experiment we observed effects up to 41.5 dpt (Marchetti et al., 1997). In addition, the 
fertilization rate at each mating time in the 2-cell experiment was consistently higher than that in 
the zygote experiment (Figure 6). This was probably due to a preferential loss of unfertilized 
eggs during the fixation procedure in the 2-cell embryo experiment. Unfertilized eggs begin to 
degenerate about 10 hr after ovulation (Marston and Chang, 1964). In our experiment, cells were 
collected about 40 hr after ovulation and it is possible that once the zona pellucida was removed 
during the fixation process, degenerating unfertilized eggs were prone to lysis and this resulted in 
an artificial increase in the fertilization rate.   
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In conclusion, we have shown that after AA exposure high levels of paternally-inherited 
chromosomal aberrations in zygotes are not selected against and lead to extensive chromosomal 
mosaicism during the first mitotic division with the majority of the resulting 2-cell embryos 
having different chromosomal aberrations in the two blastomeric metaphases. The high incidence 
of chromosomal mosaicism observed in 2-cell embryos suggests that paternally-transmitted 
chromosomal structural aberrations increase the chance of missegregation during the first mitotic 
division and may be partly responsible for the high levels of mosaicism observed in human 
preimplantation embryos.  
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Table 1 - Baseline frequencies of various chromosomal abnormalities in mouse zygotes and 2-
cell embryos 
 
 Zygotesa  2-cell embryos 
 Total No. % ± S.E.M.b  Total No. % ± S.E.M. b 
Aneuploidy 883 9 1.0 ± 0.3  327 2c 0.6 ± 0.5 
Numerical mosaic     327 3d 0.9 ± 0.4 
Triploidy 883 27 3.1 ± 0.7  327 11e 3.4 ± 0.5 
Structural aberrations 922 5 0.5 ± 0.3  358 6f 1.7 ± 0.2g 
 
aData from Marchetti et al. 1996; 1997; 2001. 
bStandard error of the mean. 
c2-cell embryos with 41 chromosomes in both metaphases. 
d2-cell embryos with 41 chromosomes in one metaphase, and 39 in the other. 
e2-cell embryos with 60 chromosomes in both metaphases. 
fAll six 2-cell embryos were structural mosaic, i.e., one metaphase showed the aberrations while 
the other metaphase appeared normal. 
gP=0.08 vs zygotes (Fisher's exact test).
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Table 2 - Effects of paternal treatment with acrylamide (5 x 50 mg/kg) on fertilization rate and embryonic progression through the first two cell 
cycles of development mice. 
      2-Cell embryos 
Days Total Fertilizedb 1-cell embryos Totalc  Interphasee  Asynchronouse  Metaphasee 
p.t.a embryos No. % ± S.E.M.d No % ± S.E.M.d No. % ± S.E.M.d  No. % ± S.E.M.d  No. % ± S.E.M.d  No. % ± S.E.M.d 
control 614 512 83.4 ± 2.3 61 11.9 ± 3.4 451 88.1 ± 3.4  12 2.7 ± 1.2  10 2.2 ± 0.6  429 95.1 ± 1.6 
2.5 717 552 77.0 ± 2.1 118 21.4 ± 3.1 434 78.6 ± 3.1  112 25.8 ± 2.7
f  34 7.8 ± 4.4  288 66.4 ± 6.2
f 
6.5 936 713 76.2 ± 1.7 153 21.5 ± 2.2 560 78.5 ± 2.2  179 32.0 ± 3.8
f  15 2.7 ± 0.8  366 65.4 ± 3.1
f 
9.5 1178 838 71.1 ± 2.8f 155 18.5 ± 2.5 683 81.5 ± 2.5  161 23.6 ± 3.2
f  37 5.4 ± 1.0  485 71.0 ± 3.3
f 
12.5 872 684 78.4 ± 1.4 86 12.6 ± 1.2 598 87.4 ± 1.2  83 13.9 ± 2.0
f  17 2.8 ± 1.1  498 83.3 ± 3.0
g 
20.5 925 758 81.9 ± 3.4 136 17.9 ± 2.5 622 82.1 ± 2.5  78 12.5 ± 5.1
g  20 3.2 ± 0.2  524 84.2 ± 5.0 
27.5 981 820 83.6 ± 0.8 177 21.6 ± 3.0 643 78.4 ± 3.0  57 8.9 ± 3.0  16 2.5 ± 1.0  560 87.1 ± 4.0 
41.5 669 589 88.0 ± 1.6 72 12.2 ± 1.3 517 87.8 ± 1.3  32 6.2 ± 1.7  12 2.3 ± 1.0  476 91.5 ± 2.5 
48.5 440 362 82.3 ± 0.1 56 15.5 ± 3.1 306 84.5 ± 3.1  6 2.0 ± 1.1  6 2.0 ± 1.4  294 96.1 ± 0.6 
aPost-treatment; days between the last AA injection and mating. 
b(Unfertilized eggs/Total number of eggs and embryos); Indicator of prefertilization toxicity 
c(2-cell embryos/Fertilized eggs); indicator of postfertilization toxicity 
dStandard error of the mean. 
ePercentages on total 2-cell embryos 
fP<0.01 vs. controls (ANOVA) 
gP<0.05 vs. controls (ANOVA) 
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Table 3 – Mosaicism for structural chromosomal aberrations detected by PAINT/DAPI analysis 
in 2-cell embryo metaphases after paternal treatment with acrylamide (5 x 50 mg/kg) 
in mice  
Days No. of Mosaic Non-Mosaic Total % ± S.E.M.b 







control 358 0 6 0 6 1.7 ± 0.2 
2.5 149 58 17 27 102 68.5 ± 5.7f 
6.5 143 89 17 11 117 81.8 ± 1.6f,g 
9.5 212 57 33 29 110 51.9 ± 4.4f 
12.5 307 25 20 13 58 18.9 ± 4.1f 
20.5 303 1 13 1 15 5.0 ± 1.9h 
27.5 298 0 6 4 10 3.4 ± 1.6 
41.5 344 0 5 0 5 1.5 ± 0.3 
48.5 233 0 2 0 2 0.9 ± 0.6 
aPost-treatment. 
bStandard error of the mean. 
cMosaic embryos with chromosomal aberrations in both metaphases but of different type. 
dMosaic embryos with chromosomal aberrations in only one metaphase. 
eEmbryos with apparently the same type of chromosomal aberrations in both metaphases. 
fP<0.001 vs controls (Chi-square). 
gP<0.05 vs 2.5 and 6.5 dpt (Chi-square). 
hP<0.05 vs controls (Chi-square). 
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Table 4 – Comparison of numbers and types of chromosomal structural aberrations in mouse 2-cell embryo metaphases after paternal treatment with 
acrylamide (5 x 50 mg/kg) detected by PAINT/DAPI analysis 
 
Days 2-Cell DAPI analysis  PAINT analysis 
p.t.a embryos Total Dicentrics Fragments Other  Cell- Total Dicentrics Fragments Translc Insertions Other 
       eqb       
control 358 0.02 0 0.01 0.01  103 0 0 0 0 0 0 
2.5 149 2.37 0.85 1.27 0.30  55 2.38 0.60 0.58 1.15 0.04 0.02 
6.5 143 3.80 1.15 1.98 0.66  39 3.36 0.61 0.67 1.87 0.15 0.05 
9.5 212 1.58 0.52 0.72 0.34  74 1.48 0.27 0.20 0.89 0 0.12 
12.5 307 0.42 0.17 0.14 0.11  109 0.46 0.11 0.05 0.25 0.01 0.04 
20.5 303 0.05 0.02 0.03 0.01  112 0.04 0 0 0.04 0 0 
27.5 298 0.03 0 0.02 0.02  110 0.05 0 0 0.05 0 0 
41.5 344 0.02 0.01 0.01 0.01  126 0.01 0 0 0 0 0.08 
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Table 5 - Numerical aberrations in mouse 2-cell embryo metaphases after paternal treatment 
with acrylamide (5 x 50 mg/kg) detected by PAINT/DAPI analysis 
 
Days No. of Embryos with numerical abnormalities (%) 
p.t.a embryos Diploidb Hypodiploidc Hyperdiploidd Triploide Mosaicf 
control 327 87.3 4.4 6.6 0.6 3.4 0.9 
2.5 107 49.5 29.0 16.8 0.9 0.9 3.7g 
6.5 101 20.8 61.4 14.9 0 4.7 3.0 
9.5 153 60.8 22.9 13.1 0 2.5 3.3 
12.5 255 82.4 7.5 8.6 0 1.5 1.6 
20.5 267 66.3 14.2 18.4 0.4 1.8 0.7 
27.5 246 77.6 5.7 14.6 0.8 2.3 1.2 
41.5 301 82.4 10.3 82.4 1.7 2.3 1.3 
48.5 197 91.9 1.5 4.1 1.0 1.5 1.5 
aPost-treatment. 
bEmbryos with 40 chromosomes in both metaphases. 
cEmbryos with <40 chromosomes in one (first percentage) or both metaphases (second 
percentage). 
dEmbryos with 41 chromosomes in both metaphases. 
eEmbryos with ~60 chromosomes in both metaphases. 
fEmbryos with 41 chromosomes in one metaphase and 39 in the other. 
gP=0.067 (Fisher Exact). 
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FIGURE LEGENDS 
 
Figure 1. Photomicrographs of 2-cell embryo metaphases analyzed by the PAINT/DAPI 
method. Cells were hybridized with chromosome-specific composite DNA probes for 
chromosomes 1, 2, 3, and X (labeled with biotin and signaled with the green dye 
FITC) and chromosome Y (labeled with digoxigenin and labeled with the red dye 
rhodamine). A: PAINT image of a normal 2-Cl embryo. In each metaphase the Y 
chromosome (in red) and 7 painted chromosomes (in green), three couples of 
autosomes and one copy of the X chromosomes, can be observed.  B: Asynchronous 
2-cell embryo with one blastomere already at the metaphase stage (right) and the 
other still in interphase (left). C-D: The two metaphases of a mosaic 2-Cl embryo 
showing different chromosomal abnormalities. Arrowheads indicate acentric 
fragments, while arrows indicate dicentrics. E: Numerically mosaic embryo 
originated by the nondisjunction of chromosome Y during the first mitotic division. 
Note that one metaphase has two chromosomes Y and the other none. Bars represent 
10 µm.  
 
Figure 2. Comparisons of the number and types of chromosomal aberrations detected in 
zygotes (white columns) and 2-cell embryos (gray columns) by PAINT/DAPI 
analysis after paternal exposure to 5 x 50 mg/kg acrylamide. A: Sums of total 
aberrations, dicentrics, acentric fragments and translocations. B: Number of dicentrics 
per metaphase in zygotes and -2-cell embryons at the four time points with the 
highest levels of abnormal embryos. C: Number of acentric fragments per metaphase 
in zygotes and -2-cell embryons at the four time points with the highest levels of 
abnormal embryos. Bars represent the standard error. See text for explanation. 
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Figure 3. Comparison of the percentages of 2-cell embryos with unstable chromosome 
aberrations versus the percentages of zygotes with unstable aberrations (gray column) 
and of dead implants (black columns) by PAINT/DAPI analysis after paternal 
exposure to 5 x 50 mg/kg acrylamide. For 2-cell embryos, the fraction of mosaic 
embryos with unstable aberrations in one, or both metaphases, and non-mosaic 
embryos with the apparently same type of abnormality is given. Bars represent the 
standard error.  
 
Figure 4.  Comparison of the frequencies of 2-cell embryos with stable aberrations by 
PAINT/DAPI analysis after paternal exposure to 5 x 50 mg/kg acrylamide with those 
obtained in zygotes (Marchetti et al 1997) and in standard tests heritable translocation 
test (Adler, 1990; Shelby et al 1987). Bar represent the 95% confidence interval. 
 
Figure 5.  Comparison of the time course of induction of chromosomal aberrations in zygotes 
(white circles) and 2-cell embryos (black squares) after paternal exposure to 5 x 50 
mg/kg acrylamide. Bars represent the standard errors. Timepoints without bars 
represent data from a single mating. The last 4 timepoints are presented in expanded 
version in the insert. 
 
Figure 6. Comparison of the time course of induction of prefertilization toxicity between the 
studies in zygotes (white circles) and 2-cell embryos (black squares) after paternal 
exposure to 5 x 50 mg/kg acrylamide. The percentages of unfertilized eggs are 
reported. Bars represent the standard errors. Timepoints without bars represent data 
from a single mating.
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